ZYRTEC õhukese polümeerikattega tablett Estonia - estonio - Ravimiamet

zyrtec õhukese polümeerikattega tablett

lex ano uab - tsetirisiin - õhukese polümeerikattega tablett - 10mg 30tk

ABIRATERONE OLAINFARM õhukese polümeerikattega tablett Estonia - estonio - Ravimiamet

abiraterone olainfarm õhukese polümeerikattega tablett

olainfarm as - abirateroon - õhukese polümeerikattega tablett - 500mg 56tk; 500mg 60tk

ABIRATERONE OLAINFARM tablett Estonia - estonio - Ravimiamet

abiraterone olainfarm tablett

olainfarm as - abirateroon - tablett - 250mg 120tk

Locametz Unión Europea - estonio - EMA (European Medicines Agency)

locametz

novartis europharm limited  - gozetotide - radionukliidi pildistamine - diagnostilised radiofarmatseutilised ühendid - see ravim on mõeldud ainult diagnostiliseks kasutamiseks. locametz, after radiolabelling with gallium 68, is indicated for the detection of prostate specific membrane antigen (psma) positive lesions with positron emission tomography (pet) in adults with prostate cancer (pca) in the following clinical settings:primary staging of patients with high risk pca prior to primary curative therapy,suspected pca recurrence in patients with increasing levels of serum prostate specific antigen (psa) after primary curative therapy,identification of patients with psma positive progressive metastatic castration resistant prostate cancer (mcrpc) for whom psma targeted therapy is indicated (see section 4.

Pylclari Unión Europea - estonio - EMA (European Medicines Agency)

pylclari

curium pet france - piflufolastat (18f) - eesnäärmevähk - diagnostilised radiofarmatseutilised ühendid - see ravim on mõeldud ainult diagnostiliseks kasutamiseks. pylclari is indicated for the detection of prostate-specific membrane antigen (psma) positive lesions with positron emission tomography (pet) in adults with prostate cancer (pca) in the following clinical settings:primary staging of patients with high-risk pca prior to initial curative therapy,to localize recurrence of pca in patients with a suspected recurrence based on increasing serum prostate-specific antigen (psa) levels after primary treatment with curative intent. pylclari is indicated for use with positron emission tomography (pet).

Axumin Unión Europea - estonio - EMA (European Medicines Agency)

axumin

blue earth diagnostics ireland ltd - fluciclovine (18f) - prostatic neoplasms; radionuclide imaging - diagnostilised radiofarmatseutilised ühendid - see ravim on mõeldud ainult diagnostiliseks kasutamiseks. axumin on näidustatud positronemissioontomograafia (pet) pildindus avastada kordumise eesnäärmevähi täiskasvanud mehed, kellel kahtlustatakse kordumise põhineb vere kõrgenenud eesnäärmevähi spetsiifilise antigeeni (psa) taseme pärast esmast tervendavat ravi.

PROSTATILEN süstelahuse pulber Estonia - estonio - Ravimiamet

prostatilen süstelahuse pulber

citomed mb npk zao - prostata ekstrakt - süstelahuse pulber - 5mg 5tk

PROSTATILEN rektaalsuposiit Estonia - estonio - Ravimiamet

prostatilen rektaalsuposiit

lekhim-harkov - prostata ekstrakt - rektaalsuposiit - 30mg 5tk

VITAPROST süstelahuse pulber Estonia - estonio - Ravimiamet

vitaprost süstelahuse pulber

biopharma llc - prostata ekstrakt - süstelahuse pulber - 10mg 10tk

TENLORIS õhukese polümeerikattega tablett Estonia - estonio - Ravimiamet

tenloris õhukese polümeerikattega tablett

krka, d.d., novo mesto - losartaan+amlodipiin - õhukese polümeerikattega tablett - 50mg+5mg 10tk; 50mg+5mg 60tk; 50mg+5mg 56tk; 50mg+5mg 28tk; 50mg+5mg 84tk